Literature DB >> 31375888

Malignancy risk in Korean male patients with ankylosing spondylitis.

Bora Nam1, Hyoungyoung Kim1, Eun Jin Jang2, Soo-Kyung Cho1, Yoon-Kyoung Sung1, Tae-Hwan Kim3.   

Abstract

The objective of this study is to determine the overall and specific cancer risks in male patients with ankylosing spondylitis (AS). From the claims database of the Health Insurance and Review Assessment, male patients with AS without prior cancer history were selected (n = 21,780). Stratified random samples of claims data were used as a reference general male population group (n = 342,361). Incidence rates of overall and types of cancer were presented as number of events per 10,000 person-years with 95% confidence interval (CI). A standardized incidence ratio (SIR) was used to represent the association between AS and cancer, accounting for person-years at risk. Compared to a general male population group, the overall incidence of cancer was increased in male patients with AS (SIR 1.25, 95% CI 1.15-1.36). For specific malignancy types, the risks of male reproductive system malignancy (SIR 1.97, 95% CI 1.59-2.35) and pancreatic cancer (SIR 1.75, 95% CI 1.12-2.37) were increased. Male patients with AS had increased cancer risk, especially for male reproductive system and pancreatic cancer.

Entities:  

Keywords:  Ankylosing spondylitis; Cancer; Risk; Standardized incidence ratio

Mesh:

Year:  2019        PMID: 31375888     DOI: 10.1007/s00296-019-04408-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

Review 1.  No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis.

Authors:  R H Straub; S Struhárová; J Schölmerich; P Härle
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  Celecoxib for the prevention of sporadic colorectal adenomas.

Authors:  Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Scott D Solomon; KyungMann Kim; Jie Tang; Rebecca B Rosenstein; Janet Wittes; Donald Corle; Timothy M Hess; G Mabel Woloj; Frédéric Boisserie; William F Anderson; Jaye L Viner; Donya Bagheri; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Gary B Gordon; Ernest T Hawk
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

3.  High-grade prostatic intraepithelial neoplasia.

Authors:  David G Bostwick; Lina Liu; Michael K Brawer; Junqi Qian
Journal:  Rev Urol       Date:  2004

4.  Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.

Authors:  J Askling; L Klareskog; P Blomqvist; M Fored; N Feltelius
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

Review 5.  Ankylosing spondylitis and bowel disease.

Authors:  Martin Rudwaleit; Dominique Baeten
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

Review 6.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

Review 7.  Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Alaa Rostom; Catherine Dubé; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

8.  Risk of haematological malignancies in HLA-B27 carriers.

Authors:  W Y Au; B R Hawkins; N Cheng; A K Lie; R Liang; Y L Kwong
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study.

Authors:  N Feltelius; A Ekbom; P Blomqvist
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

View more
  2 in total

1.  Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database.

Authors:  Mohamad Bittar; Sali Merjanah; Reem Alkilany; Marina Magrey
Journal:  BMC Rheumatol       Date:  2022-06-30

2.  Ankylosing Spondylitis and the Risk of Lung Cancer: A Meta-Analysis and Mendelian Randomization.

Authors:  Yiyuan Ao; Yaokai Wen; Yutian Li; Haoxin Peng; Xiangrong Wu; Zhufeng Wang; Yu Jiang; Yuechun Lin; Shuben Li
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.